Virus inactivation in hemoglobin solution by heat treatment

被引:21
作者
Abe, H
Ikebuchi, K
Hirayama, J
Fujihara, M
Takeoka, S
Sakai, H
Tsuchida, E [1 ]
Ikeda, H
机构
[1] Waseda Univ, Dept Polymer Chem, Adv Res Inst Sci & Engn, Tokyo 1698555, Japan
[2] Hokkaido Res Cross Blood Ctr, Sapporo, Hokkaido 0630002, Japan
来源
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY | 2001年 / 29卷 / 05期
关键词
D O I
10.1081/BIO-100106921
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To increase the safety of stroma-free hemoglobin solution (SFH) as an artificial oxygen carrier source, we investigated the effect of heat treatment on virus inactivation in hemoglobin solution. The hemoglobin solution spiked with vesicular stomatitis virus (VSV) was treated at 60 degreesC for 1 hr under either an air or CO atmosphere. VSV was inactivated at >5.8 log(10) and >6.0 log(10) under the air and CO atmosphere, respectively. Although the methemoglobin rate increased after the heat treatment under the air atmosphere, no methemoglobin formation was observed by the treatment under the CO atmosphere. Isoelectric focusing analysis revealed the denaturation of hemoglobin after the heat treatment under the air, while hemoglobin banding was not altered in the carbonylated condition. Some protein bands other than hemoglobin were weakened or disappeared on SDS-PAGE after the heat treatment under both conditions. In addition, the hemoglobin concentration in the SFH was higher after the heat treatment than before the treatment. These findings indicate that the heat treatment under the CO atmosphere inactivates viruses without hemoglobin denaturation, and hence, this method is a promising approach to prepare a safer SFH as artificial oxygen carriers.
引用
收藏
页码:381 / 388
页数:8
相关论文
共 12 条
[1]   Removal of parvovirus B19 from hemoglobin solution by nanofiltration [J].
Abe, H ;
Sugawara, H ;
Hirayama, J ;
Ihara, H ;
Kato, T ;
Ikeda, H ;
Ikebuchi, K .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2000, 28 (05) :375-383
[2]   Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb™) for viral inactivation [J].
Azari, M ;
Ebeling, A ;
Baker, R ;
Burhop, K ;
Camacho, T ;
Estep, T ;
Guzder, S ;
Marshall, T ;
Rohn, K ;
Sarajari, R ;
Boose, JA ;
Gauvin, G ;
Horner, R ;
Lu, B ;
Pearson, L ;
Vacante, D .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1998, 26 (5-6) :577-582
[3]  
Hirayama J, 2000, PHOTOCHEM PHOTOBIOL, V71, P90, DOI 10.1562/0031-8655(2000)071<0090:VPISFH>2.0.CO
[4]  
2
[5]  
Hirayama J, 1998, BIOL PHARM BULL, V21, P621, DOI 10.1248/bpb.21.621
[6]  
REED L. J., 1938, AMER JOUR HYG, V27, P493
[7]   Physical properties of hemoglobin vesicles as red cell substitutes [J].
Sakai, H ;
Hamada, K ;
Takeoka, S ;
Nishide, H ;
Tsuchida, E .
BIOTECHNOLOGY PROGRESS, 1996, 12 (01) :119-125
[8]   Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state [J].
Sakai, H ;
Tomiyama, K ;
Sou, K ;
Takeoka, S ;
Tsuchida, E .
BIOCONJUGATE CHEMISTRY, 2000, 11 (03) :425-432
[9]   CONVENIENT METHOD TO PURIFY HEMOGLOBIN [J].
SAKAI, H ;
TAKEOKA, S ;
NISHIDE, H ;
TSUCHIDA, E .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1994, 22 (03) :651-656
[10]   The risk of transfusion-transmitted viral infections [J].
Schreiber, GB ;
Busch, MP ;
Kleinman, SH ;
Korelitz, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1685-1690